Table 5.
Dataset | Patients | Healthy controls |
---|---|---|
OASIS-200 | ||
Number of subjects | 100 | 100 |
Age (range, years) | 62–96 | 59–94 |
Age (mean ± SD, years) | 76.70 ± 7.10 | 75.50 ± 9.10 |
Gender (women/men) | 59/41 | 73/27 |
ADNI | ||
Number of subjects | 100 | 100 |
Age (range, years) | 56–89 | 58–95 |
Age (mean ± SD, years) | 74.28 ± 7.96 | 75.04 ± 7.11 |
Gender (women/men) | 44/56 | 52/48 |
PPMI | ||
Number of subjects | 100 | 100 |
Age (range, years) | 34–82 | 31–83 |
Age (mean ± SD, years) | 61.71 ± 9.99 | 61.91 ± 11.52 |
Gender (women/men) | 40/60 | 36/64 |
Versilia | ||
Number of subjects | 17 | 17 |
Age (range, years) | 48–78 | 54–77 |
Age (mean ± SD, years) | 64 ± 7.21 | 64.00 ± 7.00 |
Gender (women/men) | 4/13 | 5/12 |
The same information for the OASIS-34 datasets has been reported in Supplementary Table S5.
AD Alzheimer’s disease, ADNI Alzheimer’s Disease Neuroimaging Initiative, OASIS open access series of imaging studies, PD Parkinson’s disease, PPMI Parkinson’s Progression Markers Initiative, SD standard deviation.